Filing Flows › Whitehawk Therapeutics (WHWK) › Recalls, complaints & regulation
Whitehawk Therapeutics (WHWK): clinical trials
Whitehawk Therapeutics (WHWK) beyond its filings: 2 active clinical trials.
Whitehawk Therapeutics' latest quarter
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Whitehawk Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.